Brightseed
PrivateLast Round
Grant
Dec 19, 2023
Est. Valuation
$300M
Total Funding Raised
$146.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Brightseed is a biotechnology company that provides an AI-powered innovation platform for health and life sciences companies to discover, validate, and commercialize natural bioactive compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brightseed Comparables
Compare Brightseed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuritas | 83% | |
| One Bio | 79% | |
| The Live Green Co | 78% |
Brightseed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 19, 2023 | ||||
| Series B | May 9, 2022 | ||||
| Grant | Jul 1, 2021 | ||||
| Series A Extension | Sep 15, 2020 | ||||
| Series A | Jun 11, 2020 |
Brightseed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A Extension, Seed, Series A |
| Conti Ventures | Seed |
| Germin8 Ventures | Seed, Series A, Series B, Series A Extension |
| Lewis & Clark Partners | Series B, Series A Extension |
| The Bill & Melinda Gates Foundation Trust | Grant |
| S2G Investments | Seed, Series A, Series B, Series A Extension |
| AgFunder | Series B, Series A Extension, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 187% MoM, reaching 3.6K.
- Mar 25, 2026
Launched an Innovation Platform for plant bioactives and health benefits.
Brightseed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brightseed's valuation, stock price, and market status.
Is Brightseed a public or private company?
Brightseed is a private company.
What is the current stock price of Brightseed?
Brightseed is a private company, so its shares have no public market price. Caplight tracks Brightseed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brightseed worth (valuation)?
Brightseed's valuation is estimated at $300.0M based on funding round data.
Can I buy Brightseed stock?
Brightseed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brightseed's last funding round?
Brightseed's most recent funding round was Grant on December 19, 2023.
Who are the main investors in Brightseed?
Key investors in Brightseed include Horizons Ventures, Lewis & Clark Partners, The Bill & Melinda Gates Foundation Trust.
Will Brightseed IPO soon?
No public IPO plans have been announced for Brightseed.
How can I track Brightseed secondary market activity?
Caplight tracks bids, offers, and trades in Brightseed's shares on secondary markets.